McArdle disease does not affect skeletal muscle fibre type profiles in humans
Tertius Abraham Kohn,
Timothy David Noakes,
Dale Elizabeth Rae,
Juan Carlos Rubio,
Alfredo Santalla,
Gisela Nogales-Gadea,
Tomas Pinós,
Miguel A. Martín,
Joaquin Arenas,
Alejandro Lucia
Affiliations
Tertius Abraham Kohn
UCT/MRC Research Unit for Exercise Science and Sports Medicine, Department of Human Biology, University of Cape Town, PO Box 115, Newlands 7725, South Africa
Timothy David Noakes
UCT/MRC Research Unit for Exercise Science and Sports Medicine, Department of Human Biology, University of Cape Town, PO Box 115, Newlands 7725, South Africa
Dale Elizabeth Rae
UCT/MRC Research Unit for Exercise Science and Sports Medicine, Department of Human Biology, University of Cape Town, PO Box 115, Newlands 7725, South Africa
Juan Carlos Rubio
Mitochondrial and Neuromuscular Diseases Laboratory, i+12 Research Institute, Hospital 12 de Octubre, 28041 Madrid, Spain
Alfredo Santalla
Department of Sport Science, Universidad Pablo de Olavide, 41013 Seville, Spain
Gisela Nogales-Gadea
Neuromuscular Diseases Unit, Institut de Recerca del Hospital de la Santa Creu i Sant Pau, Universitat Autónoma de Barcelona, 08193 Barcelona, Spain
Tomas Pinós
Departament de Patologia Mitocondrial i Neuromuscular, Hospital Universitari Vall d'Hebron, Institut de Recerca (VHIR), Universitat Autónoma de Barcelona, 08193 Barcelona, Spain
Miguel A. Martín
Mitochondrial and Neuromuscular Diseases Laboratory, i+12 Research Institute, Hospital 12 de Octubre, 28041 Madrid, Spain
Joaquin Arenas
Mitochondrial and Neuromuscular Diseases Laboratory, i+12 Research Institute, Hospital 12 de Octubre, 28041 Madrid, Spain
Alejandro Lucia
Mitochondrial and Neuromuscular Diseases Laboratory, i+12 Research Institute, Hospital 12 de Octubre, 28041 Madrid, Spain
Patients suffering from glycogen storage disease V (McArdle disease) were shown to have higher surface electrical activity in their skeletal muscles when exercising at the same intensity as their healthy counterparts, indicating more muscle fibre recruitment. To explain this phenomenon, this study investigated whether muscle fibre type is shifted towards a predominance in type I fibres as a consequence of the disease. Muscle biopsies from the Biceps brachii (BB) (n = 9) or Vastus lateralis (VL) (n = 8) were collected over a 13-year period from male and female patients diagnosed with McArdle disease, analysed for myosin heavy chain (MHC) isoform content using SDS-PAGE, and compared to healthy controls (BB: n = 3; VL: n = 10). All three isoforms were expressed and no difference in isoform expression in VL was found between the McArdle patients and healthy controls (MHC I: 33±19% vs. 43±7%; MHC IIa: 52±9% vs. 40±7%; MHC IIx: 15±18% vs. 17±9%). Similarly, the BB isoform content was also not different between the two groups (MHC I: 33±14% vs. 30±11%; MHC IIa: 46±17% vs. 39±5%; MHC IIx: 21±13% vs. 31±14%). In conclusion, fibre type distribution does not seem to explain the higher surface EMG in McArdle patients. Future studies need to investigate muscle fibre size and contractility of McArdle patients.